Matches in Nanopublications for { ?s ?p "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274770.RAf39orT6aOl-p0IWydTsVG2CZlEV_j5_lBB1H6H5Yhxg130_provenance.
- NP515886.RApuHRG6596xXuEYfYx41I2fEwoNO5waUENLpdg0q-RV0130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515886.RApuHRG6596xXuEYfYx41I2fEwoNO5waUENLpdg0q-RV0130_provenance.
- assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP815136.RA5mcOAqZnBOR7noyS0rK0hP2q-6RQDfkdwUM61o5B7z4130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815136.RA5mcOAqZnBOR7noyS0rK0hP2q-6RQDfkdwUM61o5B7z4130_provenance.
- assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP946824.RAb6mre2PqVRq6kStTukgEPfVLdXzpvF-tjaLXYanZul4130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946824.RAb6mre2PqVRq6kStTukgEPfVLdXzpvF-tjaLXYanZul4130_provenance.
- NP285991.RABxvY2aePjbePJkd1GueGy7Y9T8rVFeU4Pk8gDcccB7o130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285991.RABxvY2aePjbePJkd1GueGy7Y9T8rVFeU4Pk8gDcccB7o130_provenance.
- NP691025.RABJMBhH-qFYlsipVpl8juw7GdKr8-VNMIsQhyxU_4onw130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691025.RABJMBhH-qFYlsipVpl8juw7GdKr8-VNMIsQhyxU_4onw130_provenance.
- NP286134.RA3lu0oub9V5I0179X9mHDCSA5LTadDrJCNazoroYF2A8130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286134.RA3lu0oub9V5I0179X9mHDCSA5LTadDrJCNazoroYF2A8130_provenance.
- NP690936.RA80dSN_xomTF3kP_MR1tYiMb5c56v1_KLg7WlAMjoRcw130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690936.RA80dSN_xomTF3kP_MR1tYiMb5c56v1_KLg7WlAMjoRcw130_provenance.
- NP946825.RAESoy2AiRKoTtQuTpk3SiUjRE0TVhxDZy_O5MDkgtSto130_assertion description "[Hypermethylation of SFRP-1, DKK-3 and RUNX-3 was significantly associated with an increased risk of ESCC recurrence (P = 0.001, 0.003 and 0.001 for SFRP-1, DKK-3 and RUNX3, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946825.RAESoy2AiRKoTtQuTpk3SiUjRE0TVhxDZy_O5MDkgtSto130_provenance.